放射科与放疗科协作勾画下咽癌靶区
该研究回顾性纳入2009—2015年接受根治性放疗的54例下咽癌患者,在靶区勾画中引入头颈放射科专家意见并更新勾画指南,将新靶区与原始勾画进行定量和定性比较,并分析局部区域失败与剂量、靶区的关系。结果显示原发肿瘤GTV和CTV显著缩小,原始勾画存在较大高估,提示放射科经验整合可能缩小照射体积并减少不良反应。
要点
- 引入放射科经验后原发肿瘤GTV由14.4降至9.2 cm3(-47%),CTV由203.7降至93.8 cm3(-54%)。
- 原始原发肿瘤GTV仅39%、淋巴结GTV仅19%被评定为可接受。
核心结论
- 在下咽癌靶区勾画中整合头颈放射科专家经验并更新勾画指南,会使肿瘤体积发生大幅变化,并可能缩小放疗体积从而减少不良反应。
研究设计与样本
- 回顾性研究,纳入2009—2015年间接受根治性放疗的下咽癌患者54例。
- 按整合头颈放射科经验及更新勾画指南后的标准重新定义靶区,并与原始勾画进行定量和定性比较。
- 分析局部区域失败与放疗剂量及靶区体积的关系。
主要发现
- 原发肿瘤GTV从14.4降至9.2 cm3(-47%),CTV从203.7降至93.8 cm3(-54%)。
- 定量指标提示原始GTV被大幅高估:Dice系数0.58±0.2 SD,Jaccard指数0.44±0.19 SD,阳性预测值0.53±0.24 SD。
- 原始原发肿瘤GTV仅39%、淋巴结GTV仅19%被评定为可接受。
- 3年和5年局部区域无进展生存率分别为75.5%和66.6%。
关键数值与推荐
- 原发肿瘤GTV由14.4降至9.2 cm3(-47%),CTV由203.7降至93.8 cm3(-54%)。
- Dice系数0.58±0.2 SD,Jaccard指数0.44±0.19 SD,阳性预测值0.53±0.24 SD。
- 原始原发肿瘤GTV可接受比例为39%,淋巴结GTV可接受比例为19%。
临床怎么用
- 下咽癌根治性放疗靶区勾画可引入头颈放射科专家参与,以识别并纠正GTV与CTV的过度勾画。
- 勾画修订后应重新评估剂量分布与复发模式,关注缩小体积后野内与边缘复发的平衡。
局限性
- 为单中心回顾性研究,样本量54例。
- 新靶区与原始勾画的比较依赖评定者的可接受性判断,缺乏前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Target definition is one of the greatest uncertainties in the radiotherapy process. We aimed to investigate whether a radiologist specialized in head and neck can improve the target definition of hypopharyngeal cancers. MATERIALS AND METHODS: We retrospectively identified 54 patients with hypopharyngeal cancer who received curative-intent radiotherapy between 2009-2015. New target structures were defined incorporating head and neck radiology expertise and updated delineation guidelines. The new structures were subsequently compared both quantitively and qualitatively to the original delineations. Loco-regional failures were analyzed in relation to radiotherapy dose and target volumes. RESULTS: There was a significant reduction in gross tumour volume (GTV) for the primary tumour, decreasing from 14.4 to 9.2 cm3 (-47 %), and in clinical target volume (CTV), decreasing from 203.7 to 93.8 cm3 (-54 %). Mean quantitative values indicated a large overestimation of the original GTV (Dice Coefficient 0.58 ± 0.2 SD, Jaccard index 0.44 ± 0.19 SD, Positive predictive value 0.53 ± 0.24 SD). Only 39 % of the original primary tumour GTV and 19 % of the original lymph node GTV were assessed as acceptable. Twelve patients (22 %) had a locoregional recurrence. In relation to both the original radiation dose and the updated dose distribution, nine recurrences were classified as in field, two as marginal, and one could not be evaluated. The 3-year and 5-year locoregional progression free survival (PFS) was 75.5 % and 66.6 % respectively. CONCLUSION: Incorporating radiological expertise in the delineation of hypopharyngeal tumours leads to large changes in tumour volumes and possibly a decrease in radiation volumes which may lead to reduced side effects.
引用
- von Döbeln GA, Onjukka E, Ólafsdóttir HS, et al. Combining radiological and radiation oncology expertise in the delineation of hypopharyngeal tumours: potential effects on treatment volumes and patterns of failure. Clin Transl Radiat Oncol. 2025. PMID: 40757159. doi:10.1016/j.ctro.2025.101022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。